Express Scripts' Three-Year Drug Trend Forecast Projects That Three of the Four Costliest Therapy Classes Will Be Specialty Conditions ST. LOUIS, May...
Study Shows Effects of Treatment with ABILIFY MAINTENA™ (Aripiprazole) on Psychiatric Hospitalization Rates for Patients with Schizophrenia...
Vortioxetine, a new multimodal agent in development for the treatment of major depression, shows effects on cognitive function in several preclinical...
Over the past two years, two studies showed the Niaspan cholesterol drug did not benefit patients. Yet AbbVie has managed to maintain revenue...
Much to do this morning, especially as we ready the short people for school and rifle through various documents you may find interesting. Meanwhile, a few tidbits have surfaced on our radar. So grab some coffee or water and dig in...
Astellas Cutting 200 Jobs As Flomax Patent Expires (OK.com)
Israeli Court Blocks Sun's Takeover Bid For Tara (The Economic Times) Merck KGgA And Ablynx Sign $484M Development Deal (Yahoo/Reuters)
Cephalon Ends Provigial Promotion Deal With Takeda (Bloomberg News)
